<!doctype html>
<html lang="en">
  <head>
    <!-- Required meta tags -->
    <meta charset="utf-8">
    <meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">

    <!-- Bootstrap CSS -->
    <link rel="preconnect" href="https://fonts.gstatic.com">
    <link href="https://fonts.googleapis.com/css2?family=Montserrat:wght@100;200;300;400;500;600;700;800;900&display=swap" rel="stylesheet">
    
    <link rel="stylesheet" href="css/bootstrap.min.css">
    <link rel="stylesheet" href="css/style.css">

    <title>Agios</title>
  </head>
  <body>
    <nav class="navbar navbar-expand-lg navbar-dark">
      <div class="container">
        <a class="navbar-brand" href="index.html">
          <img src="images/logo.png" />
        </a>

        <ul class="navbar-nav ml-auto">
            <li class="nav-item active">
              <a class="nav-link" href="index.html">
                <img src="images/icons/home-icon.png" width="30">
              </a>
            </li>
            <li class="nav-item active">
              <a class="nav-link" href="peak-registry.html">
                <img src="images/icons/peak-registry-icon.png" width="30">
              </a>
            </li>
            <li class="nav-item active">
              <a class="nav-link" href="pkr-activator-pipeline.html">
                <img src="images/icons/pipeline-icon.png" width="30">
              </a>
            </li>
          </ul>
      </div>
    </nav>
    <main class="pipeline-details">
      <div class="container">
        <div class="row">
          <div class="col-sm-9 col-7">
            <h1 class="mb-4">Sickle Cell Disease Phase 1 (NIH CRADA)</h1>
          </div>
          <div class="col-sm-3 col-5">
            <span class="badge blue-dark float-right mt-1">STATUS: ONGOING</span>
          </div>

          <div class="col-md-8">
            <h4 class="font-weight-normal mb-3">Phase 1, non-randomized, open-lable dose escalation study of mitapivat in adults with Sickle Cell Disease</h4>
          </div>
          <div class="col-md-8">
            <div class="block">
              <div class="row">
                <div class="col-md-12">
                  <img src="images/nih-crada.png" class="mb-0" />
                </div>
              </div>
            </div>
          </div>
          <div class="col-md-4">
              <div class="block side-block-container">
                <div class="side-block">
                  <p class="mb-1"><strong>Key Inclusion Criteria</strong></p>
                  <ul class="mb-0 pl-20">
                      <li>Adults (age â‰¥18 years) with stable Hb SS disease</li>
                      <li>No transfusions or changes in hydroxyurea/L-glutamine within 90 days</li>
                  </ul>
                </div>
                <div class="side-block side-block-gray">
                  <p class="mb-1"><strong>Primary Endpoint</strong></p>
                  <ul class="mb-0 pl-20">
                      <li>Safety and tolerability
                        <ul>
                          <li>Changes in Hb and hemolytic markers</li>
                        </ul>
                      </li>
                  </ul>
                </div>
                <div class="side-block">
                  <p class="mb-1"><strong>Secondary Endpoints</strong></p>
                  <ul class="mb-0 pl-20">
                      <li>Pharmacokinetics</li>
                      <li>2,3-DPG and ATP levels</li>
                      <li>O2 dissociation and sickling tendency</li>
                  </ul>
                </div>
              </div>
            </div>
        </div>
        <footer>
            <div class="row">
              <div class="col-md-7">
                <p class="text-left">BID = twice daily; CRADA = Cooperative Research and Development Agreement</p>
              </div>
              <div class="col-md-5">
                <p class="text-right">For full inclusion and exclusion criteria, as well as study locations, search ClinicalTrials.gov for (NCT04000165)<br/>
                  For more information (physician/HCP only), please email medinfo@agios.com<br/>
                &copy;2021 Agios Pharmaceuticals, Inc. All rights reserved.</p>
              </div>
            </div>
        </footer>
      </div>
    </main>


    <!-- Optional JavaScript -->
    <!-- jQuery first, then Popper.js, then Bootstrap JS -->
    <!-- <script src="https://code.jquery.com/jquery-3.2.1.slim.min.js" integrity="sha384-KJ3o2DKtIkvYIK3UENzmM7KCkRr/rE9/Qpg6aAZGJwFDMVNA/GpGFF93hXpG5KkN" crossorigin="anonymous"></script>
    <script src="https://cdnjs.cloudflare.com/ajax/libs/popper.js/1.12.9/umd/popper.min.js" integrity="sha384-ApNbgh9B+Y1QKtv3Rn7W3mgPxhU9K/ScQsAP7hUibX39j7fakFPskvXusvfa0b4Q" crossorigin="anonymous"></script> -->
    <script src="js/jquery-3.4.1.min.js"></script>
    <script src="js/bootstrap.min.js"></script>
  </body>
</html>